
In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular ...
Introduction Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide.1 Early-stage HCC can be effectively treated with surgical resection, radiofrequency ablation, or liver transplantation.2 However, despite the implementation of …